ÂÜÀòÂÒÂ×

Sunny Song, PhD, MBA, is an accomplished professional in the biotech and life sciences sectors, currently serving as the AVP of Business Development for Biologics at Aragen Life Sciences. With extensive experience in strategic roles, Sunny has held positions at MEDIC Life Sciences as Head of Strategy and Business Development, at WuXi Biologics in Global Business Development and Alliance Management, and has contributed significantly to R&D at Thermo Fisher Scientific and Danaher Corporation. Academic credentials include a PhD in Biochemistry and Molecular Genetics from the University of Colorado Anschutz Medical Campus and an MBA from Santa Clara University. Sunny has a proven track record in driving corporate strategy and business development, particularly in areas such as biologics, CRISPR technologies, and biopharma analytics.